LYOPHILIZED Drug Patent Profile
✉ Email this page to a colleague
When do Lyophilized patents expire, and when can generic versions of Lyophilized launch?
Lyophilized is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in LYOPHILIZED is cyclophosphamide. There are nineteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lyophilized
A generic version of LYOPHILIZED was approved as cyclophosphamide by BAXTER HLTHCARE on May 21st, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LYOPHILIZED?
- What are the global sales for LYOPHILIZED?
- What is Average Wholesale Price for LYOPHILIZED?
Summary for LYOPHILIZED
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | LYOPHILIZED at DailyMed |
US Patents and Regulatory Information for LYOPHILIZED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | LYOPHILIZED CYTOXAN | cyclophosphamide | INJECTABLE;INJECTION | 012142-006 | Dec 5, 1985 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Baxter Hlthcare | LYOPHILIZED CYTOXAN | cyclophosphamide | INJECTABLE;INJECTION | 012142-007 | Dec 10, 1985 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
